Interim report, First Quarter, 1 May 2021-31 July 2021.

MFN Publicerad: 24 Aug 2021 15:00

“New partnership with Clarivate is launched. The objective is to make it faster and easier to do data analysis powered by the combination of Qlucore Omics Explorer and Clarivate’s MetaCore™.

Net sales were SEK 1 659k (2 194).
Operating result (EBIT) amounted to SEK -4 049k (-1 730).
Net result for the period was SEK -4 078k (-1 766).
Cash flow from operations before investment activities totaled SEK -3 405k (463).
Earnings per share amounted to SEK -15,49 (-9,21).
Earnings per share after dilution were SEK -15,20 (-9,21).
Launched partnership with Clarivate to make it faster and easier to do data analysis powered by Qlucore Omics Explorer and MetaCore™.

About Qlucore

Qlucore is a leading provider of new generation intuitive bioinformatics software for research and precision and companion diagnostics. Qlucore’s mission is to make it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genomics and proteomics by providing powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics. The Qlucore Omics Explorer software is a Do-It-Yourself bioinformatics software for research in the life science, plant- and biotech industries, as well as academia. The Qlucore Diagnostics software is a platform for multi-omics companion and precision diagnostics. Qlucore was founded in 2007 at Lund University, Sweden and has today customers in about 25 countries around the world, with sales offices in Europe and North America, and distribution in several countries in Asia. www.qlucore.com

Börskollen

För dig med koll på börsen

Pressmeddelande

Interim report, First Quarter, 1 May 2021-31 July 2021.

Bifogade filer

Nyheter om Qlucore

Läses av andra just nu

Om aktien Qlucore

Senaste nytt